Continuing Coverage: Paclitaxel in PAD

 

FDA Paclitaxel Safety Panel Preview

An interview with FDA CDRH representatives discussing the upcoming advisory panel meeting to review concerns and current data on paclitaxel-eluting device use.

News

 

Two-Year Data Presented From EffPac Trial of iVascular's Luminor DCB

May 23, 2019 -- iVascular announced that the 24-month EffPac trial results were presented by Professor Ulf Teichgräber, MD, at EuroPCR held May 21 -- 24 in Paris, France.…

Studies Support Medtronic's Renal Denervation System in High-Risk Hypertensive Patients

May 22, 2019 -- Medtronic announced that late-breaking clinical data from a physician-sponsored clinical trial using the company's Symplicity renal denervation (RDN) syste…

PCR Issues Statement Supporting Continued Use of Paclitaxel-Based DCBs

May 21, 2019 -- PCR has issued a statement addressing the controversy on the use of paclitaxel drug-coated balloons (DCBs) in peripheral interventions. The statement concluded…

Philips Launches IntraSight Interventional Applications Platform

May 20, 2019 -- Royal Philips announced the launch of its IntraSight interventional applications platform. The secure, application-based platform offers a comprehensive suite …

Stryker's Neuroform Atlas Stent System Approved by FDA to Treat Intracranial Aneurysms

May 20, 2019 -- Stryker announced FDA premarket approval of its Neuroform Atlas stent system for the treatment of wide-neck intracranial aneurysms in conjunction with embolic …

Galt Medical Acquires Arrotek Medical

May 20, 2019 -- Galt Medical, a subsidiary of Theragenics Corporation and a global supplier of access and procedure products for a range of interventional and endovascular pro…

Click here for more News coverage

Paclitaxel In PAD

Current Supplement

Sponsored by BOSTON SCIENTIFIC CORPORATION

Advancing the Critical Limb Ischemia Treatment Algorithm:

Tools & Techniques for Below-the-Knee Success

Current European Supplement

Sponsored by EUMEDICA

Thrombolysis for Peripheral Arterial Thrombosis

Leading French experts discuss the place of thrombolysis in the modern era.

Device Guide

This Device Guide offers a searchable, comprehensive listing of the available vascular interventional devices in the United States.

 

Featured Center

 

Embolization

 
Vascular Market Price  Change
Abbott Laboratories $76.98  1.79%
AstraZeneca PLC $39.02  0.93%
Avinger $0.46  -3.19%
Becton Dickinson and Co $235.19  0.51%
Boston Scientific Corporation $38.47  1.80%
Cardinal Health $45.95  0.09%
Cardiovascular Systems Inc. $39.52  1.52%
Edwards Lifesciences Corp. $169.38  -0.35%
Endologix Inc. $6.66  0.30%
Johnson and Johnson $138.85  0.01%
Vascular Market Price  Change
Medtronic, Inc. $93.03  1.52%
Merit Medical Systems, Inc. $52.75  1.11%
Penumbra, Inc. $138.53  2.63%
Philips $40.48  1.15%
Ra Medical Systems $3.72  -5.82%
Silk Road Medical $45.06  -0.35%
Stryker $184.77  0.15%
Teleflex Inc. $295.61  1.26%
The Medicines Company $34.88  1.99%

@EVToday

Stay current: Follow Endovascular Today on Twitter @EVToday

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.